Bharat Parenterals LTD.

Bharat Parenterals Ltd. (BPLPHARMA) is a micro-cap Healthcare company valued at ₹1,192 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Bharat Parenterals Ltd. last traded at ₹1,726.5, down 4.26% on the day.

Recent developments

On 2026-09-11, the company announced a dividend of ₹1.00 per share, with the ex-date set for the same day. Promoter holding remained at 67.20% as of 2026-09-30, while domestic institutional holding decreased by 0.08 percentage points to 1.29%.

Financial performance

The company's business has shown mixed performance, with annual revenue rising 1.5% to ₹345 crore, but net profit remained a loss of ₹27 crore, narrowing from a ₹44 crore loss a year earlier. The latest quarter saw revenue fall 19.2% to ₹94 crore, while the net loss widened to ₹4 crore from ₹1 crore a year ago.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 3.32 times book value.

Things to watch

The company continues to report a net loss, with a net profit margin of -7.9% and return on equity of -2.5%. The latest quarter's net loss widened, and the stock is 20.8% below its 52-week high. Domestic institutional holding also declined in the quarter.

Where it stands

Bharat Parenterals Limited ended the latest quarter with a net loss of ₹4 crore, while annual net loss narrowed to ₹27 crore. The stock is 20.8% below its 52-week high, and domestic institutional holding fell by 0.08 percentage points in the quarter.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.